SAN FRANCISCO, March 08, 2016 -- Today Zephyr Health, the leading Insights-as-a-Service company, released a report that reveals a largely untapped opportunity for sales teams in Life Sciences companies; integrating global health data and predictive insights into their commercial efforts. This latest report, “Navigating your way to insights-driven customer relationships,” published in conjunction with pharmaphorum, found that the majority of both management and frontline staff see current Customer Relationship Management (CRM) systems as a valuable tool for managing activities and customers, yet to date has not helped field teams find actions for sales strategy and planning.
"Bringing predictive capabilities and insights into customer engagement strategies and solutions is a nascent but growing opportunity for Life Sciences companies to improve sales effectiveness,” said Lance Scott, chief executive officer, Zephyr Health. “We consistently hear from our customers that they want more from their existing systems, and they recognize the immense value in having market and customer intelligence integrated into their CRM for competitive advantage.”
The “Navigating Your Way to Insights-Driven Customer Relationships” survey assessed 107 frontline sales and management staff to determine where the Life Sciences industry is in its own journey of improving customer engagement. The final report provides insights and recommendations to transform customer engagement and put forward a more proactive and predictive sales strategy. For more information, download a copy of the Zephyr Health report.
About Zephyr Health
Zephyr Health is the leading insights-as-a-service company harnessing the power of the global health data to address critical business and patient needs. Zephyr Illuminate™ helps Life Sciences companies - pharmaceutical, biotech and medical device –make confident decisions faster across the entire product lifecycle with precise and predictive insights. From pre-launch to product maturity, our solutions connect data from thousands of sources across the global healthcare ecosystem to produce deep, predictive insights that our customers use to instrument their business and dramatically improve product lifecycle performance. Zephyr Health's customers include 4 of the Top 10 Pharmaceutical companies, 2 of the Top 10 Biotech Companies and 2 of the Top 10 Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Media Contact: Zephyr Health Global Communications [email protected]


China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock 



